Skip to content

Orphan Drugs: FDA October 2014 Approvals

November 4, 2014





The chart below identifies Orphan Drugs receiving FDA October 2014 approval as of 11/04/14 in ascending “Approval Date” order.

FDA October 2014 Orphan Products Receiving Approval

# Generic Name/Approval Date  Sponsor Company Indication
1 Bortezomib (Velcade Injection)/ 10.08 Millennium Pharmaceuticals Mantle Cell Lymphoma (MCL)
2 Nintedanib (Ofev)/ 10.15 Boehringer Ingelheim Pharmaceuticals Idiopathic Pulmonary Fibrosis (IPF)
3 Pirfenidone (Esbriet)/ 10.15 InterMune Idiopathic Pulmonary Fibrosis (IPF)
4 Antihemophilic factor (recombinant), porcine sequence (Obizur)/ 10.23 Baxter Healthcare Bleeding episodes in adults with acquired Hemophilia A


Please Note: “First Pigment Analysis (5893349712)” by NASA ICE (First Pigment Analysis Uploaded by russavia) [CC-BY-2.0] | Wikimedia Commons.

Copyright © 2012-2014, Orphan Druganaut Blog. All rights reserved.

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: